Description
Trucheck FemmeSafe (Breast, Ovaries, Endometrium, Cervix) is a revolutionary multicancer cancer screening test, from Datar Cancer Genetics, is based on a simple fasting blood draw anywhere in the UK and Ireland. It screens for early detection of common female cancers such as breast cancer, cervical cancer, ovarian cancer, uterine cancer or endometrial cancer. The test is suitable for general health screening and especially for those on HRT as HRT can increase the risk of some female cancers. It is recommended as an annual test.
Trucheck Femmesafe Patient Information Leaflet
Click here to learn more from Cancer Research UK about HRT
This test has been discontinued – see Trucheck Intelli that includes screening for cancers in Trucheck FemmeSafe!
